Package 70518-3359-1

{"route": ["ORAL"], "spl_id": "4b2d87e5-7714-ff90-e063-6394a90af3af", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313564"], "spl_set_id": ["de96c14b-cd74-46dd-bcce-d1fa640a6037"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-3359-1)", "package_ndc": "70518-3359-1", "marketing_start_date": "20220214"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-3359-2)", "package_ndc": "70518-3359-2", "marketing_start_date": "20251014"}, {"sample": false, "description": "14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-3359-3)", "package_ndc": "70518-3359-3", "marketing_start_date": "20260218"}], "brand_name": "Valacyclovir Hydrochloride", "product_id": "70518-3359_4b2d87e5-7714-ff90-e063-6394a90af3af", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "70518-3359", "generic_name": "Valacyclovir Hydrochloride", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir Hydrochloride", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "1 g/1"}], "application_number": "ANDA090682", "marketing_category": "ANDA", "marketing_start_date": "20220207", "listing_expiration_date": "20271231"}